Foreword
Log In to view your rate
Unlock the discounted member rate
Join first as a member, and then purchase this product at special member pricing.
With pharmaceuticals representing such an important part of the nation's economy and the health care sector, competition in the pharmaceutical industry is crucial to provide the best quality drugs for the lowest possible price. Antitrust enforcement plays a key role in ensuring competition in this industry. The past decade has featured numerous high-profile decisions, including that of the Supreme Court in FTC v. Actavis, that have fundamentally influenced the advice that practitioners give to their pharmaceutical clients.
Written for the antitrust and pharmaceutical communities, the Pharmaceutical Industry Antitrust Handbook, Second Edition is intended to provide a comprehensive and objective source about the most important antitrust issues faced by the pharmaceutical industry today. The Handbook provides an overview of the pharmaceutical industry, including the market participants, FDA regulatory structure, and background on private litigation and government enforcement. It then addresses the substantive antitrust issues presented by mergers and acquisition, joint ventures, various forms of potentially anticompetitive conduct, and distribution. Finally, it discusses the kinds of economic data that are integral to antitrust analysis for this industry.
Section of Antitrust Law
ABA Book Publishing
9781641052139
472
5030652
6x9 Paperback
4/9/2018 12:00:00 AM
Publications | Book
Health Care Mergers and Acquisitions Handbook, Second Edition
Publications | Book
Antitrust Health Care Handbook, Fourth Edition
Publications | Book
State Antitrust Enforcement Handbook, Third Edition
Audio and Video | On-Demand CLE
COVID-19: How Antitrust Enforcers Are Responding to the Global Pandemic [CC]
Audio and Video | On-Demand CLE
Adventures in Data Security Lawyering (On-Demand CLE)
Audio and Video | On-Demand CLE
Medical Coding and Billing 303 Master Class (On-Demand CLE)
May
04
Events | Webinar
Q1 2020 Developments in Healthcare and Pharma Antitrust
This teleconference program will cover an update on the recent antitrust developments in the U.S. in the health care and pharmaceuticals industries for Q1 2021.
Jan
21
Events | Webinar
The Uncertain Landscape of Privacy Regulation: An In-House Perspective
Hear from in-house counsel on how they view the evolving privacy and data protection landscape, how that could impact their businesses, and how they are navigating this uncertainty.
Mar
05
Events | Webinar
Intro to Health Care and Lifesciences for Antitrust Practitioners
Are you new to health care? Just staffed on your first lifesciences matter? Interested in expanding your antitrust practice into a new industry? Join the Health Care and Pharmaceuticals Committee for…